Eileen Cheigh

Eileen Cheigh is currently the VP of Business Assessment for the Chief Business Innovation Office at Pfizer. Eileen has been with Pfizer since August 1996 and in their current role since February 2014. Prior to their current role, they were the Senior Director of Global Strategy & Operations for the Established Products Business Unit where they oversaw the development and implementation of Pfizer's global generics expansion strategy. This included prioritizing investments across markets, project management of organic and inorganic portfolio expansion, and governance model. Under their leadership, the Established Products Business Unit met global financial targets of $1.2B in 2013 revenues and 41% growth through 2015.

Before joining Pfizer, Eileen held various roles in sales and underwriting for health insurance plans at Aetna from January 1991 to December 1994. In their role as a Sales Analyst / Insurance Underwriter, they were responsible for creating new business proposals and implementation plans for large employer health plans in very competitive West Coast health care benefits markets. Eileen also conducted research, risk assessment, and financial analysis in underwriting new policies.

Eileen Cheigh has an MBA in Health Care Management and Finance from The Wharton School and a BA in Economics and American Studies from Wesleyan University.